Triple-helical ligands for collagen-binding proteins improve cartilage extracellular matrix production in nasal chondrocytes
Source abstract
Abstract
The use of articular chondrocytes for cartilage repair is constrained by donor-site morbidity, poor proliferation, and difficulties to maintain a stable phenotype. As a result, nasal chondrocytes (NCs) have recently emerged as an alternative cell source. To better establish the potential of NCs in tissue engineering, we have explored their response to the activation of collagen-binding proteins (integrins, discoidin domain receptors (DDRs) andthe secreted protein acidic cysteine-rich (SPARC)) which are essential to cartilage homeostasis. Ligands for these proteins were synthesized as triple-helical peptides (THPs) that mimic the biological and structural properties of collagen, and were covalently linked to PEG or alginate hydrogels hosting human NCs. Compared to human adipose-tissue mesenchymal stem cells, NCs over-expressed chondrogenic markers, yielding higher Sox9 translocation and type II collagen production. THP ligands significantly improved the expression of key cartilage extracellular matrix components in hydrogels, at both the RNA and protein level, for up to 21 days of culture. In particular, THP ligands for DDRs and SPARC led to increased glycosaminoglycan and collagen deposition. In addition, THPs limited fibrocartilage formation, matrix metalloproteinase 13 expression and chondrocytes hypertrophy after 7 days of culture in hydrogels. This work introduces a biomimetic strategy to drive the early stages of the formation of an engineered cartilage tissue from NCs, by replicating key cell/collagen interactions. It provides a preliminary effort to combine an accessible cell source with functionalized biomaterials for cartilage repair.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Cell Adhesion Molecules Research · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (82)
Show source-provided references
1. Osteoarthritis pathogenesis - a complex process that involves the entire joint
2. Risk factors and burden of osteoarthritis10.1016/j.rehab.2016.01.006 ↗
3. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 201710.1136/annrheumdis-2019-216515 ↗
4. The contribution of osteoarthritis to functional limitations and disability10.1016/j.cger.2010.04.001 ↗
5. Microfracture for the treatment of cartilage defects in the knee joint - a golden standard?10.1016/j.jcot.2016.06.015 ↗
6. Activation and dedifferentiation of chondrocytes: implications in cartilage injury and repair10.1016/j.aanat.2009.05.003 ↗
7. Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic joints10.1016/j.joca.2005.12.002 ↗
8. Cartilage repair: past and future--lessons for regenerative medicine10.1111/j.1582-4934.2009.00789.x ↗
9. The role of tissue engineering in articular cartilage repair and regeneration10.1615/CritRevBiomedEng.v37.i1-2.10 ↗
10. Mesenchymal stem cell subpopulations and their heterogeneity of response to inductions revealed by single-cell RNA-seq
11. Single-cell RNA sequencing reveals the heterogeneity of adipose tissue-derived mesenchymal stem cells under chondrogenic induction10.5483/BMBRep.2023-0161 ↗
12. Toward tissue-engineering of nasal cartilages10.1016/j.actbio.2019.02.025 ↗
13. Engineered cartilage generated by nasal chondrocytes is responsive to physical forces resembling joint loading10.1002/art.23155 ↗
14. Engineered nasal cartilage for the repair of osteoarthritic knee cartilage defects10.1126/scitranslmed.aaz4499 ↗
15. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial10.1016/S0140-6736(16)31658-0 ↗
16. Contribution of neural crest-derived stem cells and nasal chondrocytes to articular cartilage regeneration10.1007/s00018-020-03567-y ↗
17. Cartilage-characteristic matrix reconstruction by sequential addition of soluble factors during expansion of human articular chondrocytes and their cultivation in collagen sponges, tissue engineering. Part C
18. Interstitial perfusion culture with specific soluble factors inhibits type I collagen production from human osteoarthritic chondrocytes in clinical-grade collagen sponges10.1371/journal.pone.0161479 ↗
19. Repair of full-thickness articular cartilage defects using IEIK13 self-assembling peptide hydrogel in a non-human primate model10.1038/s41598-021-83208-x ↗
20. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells
21. Characterization of different sources of human MSCs expanded in serum-free conditions with quantification of chondrogenic induction in 3D
22. Advancements in chondrocyte 3-dimensional embedded culture: implications for tissue engineering and regenerative medicine10.1016/j.bj.2024.100786 ↗
23. Integrin α10β1: a collagen receptor critical in skeletal development10.1007/978-94-017-9153-3_4 ↗
24. Discoidin domain receptors in disease10.1016/j.matbio.2013.12.002 ↗
25. Discoidin domain receptor functions in physiological and pathological conditions
26. Exploring the cellular and molecular mechanism of discoidin domain receptors (DDR1 and DDR2)
27. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism10.1093/embo-reports/kve094 ↗
28. Discoidin domain receptor 2 is an important modulator of BMP signaling during heterotopic bone formation10.1038/s41413-024-00391-z ↗
29. Identification of expressed genes characterizing long-term survival in malignant glioma patients10.1038/sj.onc.1209585 ↗
30. Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesis10.1002/art.22970 ↗
31. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice
32. Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model10.1016/j.ajpath.2011.05.023 ↗
33. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice10.1074/jbc.M411036200 ↗
34. Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors10.1016/0167-4889(94)90209-7 ↗
35. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures10.1002/art.1780390402 ↗
36. SPARCL1 promotes chondrocytes extracellular matrix degradation and inflammation in osteoarthritis via TNF/NF-κB pathway
37. SPARC: a potential target for functional nanomaterials and drugs10.3389/fmolb.2023.1235428 ↗
38. Increased sparc release from subchondral osteoblasts promotes articular chondrocyte degeneration under estrogen withdrawal10.1016/j.joca.2022.08.020 ↗
39. Biomaterial functionalization with triple-helical peptides for tissue engineering10.1016/j.actbio.2022.06.003 ↗
40. Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage10.1016/j.biomaterials.2010.06.001 ↗
41. Fibronectin- and collagen-mimetic ligands regulate bone marrow stromal cell chondrogenesis in three-dimensional hydrogels10.22203/eCM.v022a13 ↗
42. Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering
43. Collagen scaffolds functionalized with triple-helical peptides support 3D HUVEC culture10.1093/rb/rbaa025 ↗
44. Coupling of a specific photoreactive triple-helical peptide to crosslinked collagen films restores binding and activation of DDR2 and VWF10.1016/j.biomaterials.2018.07.050 ↗
45. A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides10.1182/blood-2006-03-011965 ↗
46. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens10.1074/jbc.275.1.35 ↗
47. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR110.1016/j.matbio.2010.10.004 ↗
48. Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen10.1074/jbc.M709290200 ↗
49. Structural basis of sequence-specific collagen recognition by SPARC10.1073/pnas.0808452105 ↗
50. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
51. Challenges in nasal cartilage tissue engineering to restore the shape and function of the nose10.1089/ten.teb.2023.0326 ↗
52. Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential10.1089/scd.2007.0049 ↗
53. Human integrin α10β1-selected mesenchymal stem cells home to cartilage defects in the rabbit knee and assume a chondrocyte-like phenotype10.1186/s13287-022-02884-2 ↗
54. The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone development10.1038/s41413-021-00182-w ↗
55. The synthesis and coupling of photoreactive collagen-based peptides to restore integrin reactivity to an inert substrate, chemically-crosslinked collagen10.1016/j.biomaterials.2016.01.044 ↗
56. Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials10.1002/jbm.a.30655 ↗
57. Repair of full-thickness articular cartilage defects using IEIK13 self-assembling peptide hydrogel in a non-human primate model10.1038/s41598-021-83208-x ↗
58. Direct perfusion improves redifferentiation of human chondrocytes in fibrin hydrogel with the deposition of cartilage pericellular matrix
59. Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice10.1371/journal.pone.0217183 ↗
60. Integrin-specific hydrogels modulate transplanted human bone marrow-derived mesenchymal stem cell survival, engraftment, and reparative activities10.1038/s41467-019-14000-9 ↗
61. Expansion of human nasal chondrocytes on macroporous microcarriers enhances redifferentiation10.1016/S0142-9612(03)00428-9 ↗
62. Hyaluronan and proteoglycan link protein1 exhibits chondroregenerative ability in injury-induced osteoarthritic animals through ALK5-SMAD2 signaling in articular chondrocytes10.1016/j.joca.2021.02.164 ↗
63. Decorin regulates cartilage pericellular matrix micromechanobiology10.1016/j.matbio.2020.11.002 ↗
64. Tuning cellular response by modular design of bioactive domains in collagen10.1016/j.biomaterials.2015.02.074 ↗
65. Tailoring collagen to engineer the cellular microenvironment
66. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide10.1002/jbm.a.10550 ↗
67. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation10.1002/jbm.a.30034 ↗
68. Structural insights into collagen binding by platelet receptor glycoprotein VI10.1182/blood.2021013614 ↗
69. Preconditioning of mesenchymal stromal cells with low-intensity ultrasound: influence on chondrogenesis and directed SOX9 signaling pathways10.1186/s13287-019-1532-2 ↗
70. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state10.1089/104454903321515922 ↗
71. SOX9 enhances aggrecan gene promoter/enhancer activity and is Up-regulated by retinoic acid in a cartilage-derived cell line, TC610.1074/jbc.275.15.10738 ↗
72. SOX9 directly regulates the type-II collagen gene10.1038/ng0697-174 ↗
73. DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs10.7554/eLife.45508 ↗
74. Integrin-dependent signal cascades in Chondrocyte mechanotransduction10.1023/B:ABME.0000017538.72511.48 ↗
75. Increased chondrogenic potential of mesenchymal cells from adipose tissue versus bone marrow-derived cells in osteoarthritic in vitro models10.1002/jcp.25651 ↗
76. Autologous cell therapy: current treatments and future prospects
77. Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites10.1042/bj3140327 ↗
78. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair10.1016/j.biomaterials.2009.12.008 ↗
79. Signaling and transcriptional regulation in osteoblast commitment and differentiation10.2741/2296 ↗
80. Multifaceted signaling regulators of chondrogenesis: implications in cartilage regeneration and tissue engineering10.1016/j.gendis.2015.09.003 ↗
81. Targeting articular Mmp13 in OA
82. Novel biomaterial strategies for controlled growth factor delivery for biomedical applications10.1038/am.2017.171 ↗